Large-scale testing (Phase 3)Study completedNCT01426815
What this trial is testing
Exploration of TNF-alpha Blockade With Golimumab in the Induction of Clinical Remission in Patients With Early Peripheral Spondyloarthritis (SpA) According to ASAS-criteria
Who this might be right for
Peripheral Spondylarthritis
University Hospital, Ghent 60